The present application is directed generally to systems and devices and methods for direct delivery of agents, e.g., pharmaceutical agents, to target spinal and neuronal anatomies, e.g., the dorsal root ganglia (DRG), for the treatment of various disorders, particularly pain and pain related disorders, such as chronic itch, sensory disorders, multiple sclerosis, post-herpetic neuralgia and the like. The system and devices of the application encompass the agents to be delivered to the target anatomy alone or in combination with electrical stimulation. The delivery device and systems as disclosed herein place the distal end of the delivery element ( 30 ), which comprises at least one agent delivery structure ( 40 ), and optionally at least one electrode, in close proximity, or in contact with or next to the target spinal anatomy, e.g., DRG. A variety of agents can be delivered using the device, including sodium channel blockers, biologies, neuroinflammatory modulators, toxins, to selectively neuromodulate the neurons. Agent delivery and/or electrical stimulation can be automated and/or can be controlled automatically or by a pre-determined program, or by a patient control pump (PCA).
